Company Announcements

Beckley Psytech announces first cohort dosed in Phase 1 clinical trial assessing safety and tolerabi...

Press release

Company Announcements

Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic ...

Company Announcements

Beckley Psytech to present at Jefferies 2021 London Healthcare Conference

Cosmo Feilding Mellen, Chief Executive Officer, will present at the Jefferies 2021 London Healthcare Conference, taking place in-person and virtually from 16th to 19th November, 2021.

Company Announcements

Beckley Psytech announces first patient has received low-dose psilocybin in world-first clinical tri...

Press Release

Company Announcements

Dr Frank Wiegand, experienced neuroscience leader joins Beckley Psytech as Chief Medical Officer

Company Announcements

Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board

Company Announcements

Beckley Psytech partners with Fluence to create psychedelic therapy training programme

Company Announcements

Beckley Psytech appoints renowned psychedelic experts to Scientific Advisory Board

Beckley Psytech, the psychedelic medicine company, has appointed a series of respected figures from the psychiatric and psychedelic research fields to its Scientific Advisory Board, bringing decades of expertise to its research programme.

Company Announcements

Meet our new scientific advisors

We are very excited to announce that Joanna Neill, Professor of Psychopharmacology at the University of Manchester, and Dr Mike Emanuel, former vice president of global clinical operations for EMEA at Johnson & Johnson, are joining our Scientific Ad... Read More

Company Announcements

Beckley Psytech receives approval for clinical trial using psychedelic agent to treat severe headach...

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has received Clinical Trial Authorisation (CTA) from the UK Medicine and Healthcare Products Regulatory Agency (MHRA) to e... Read More